Toggle navigation
Home
Search
Services
Blog
Contact
About
Toxicol Agents That Stimulates Fetal Hemoglobin Product
Loveday, Kenneth S.
American Biogenics Corporation, Woburn, MA, United States
Search 8 grants from Kenneth Loveday
Search grants from American Biogenics Corporation
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Fred Hutchinson Cancer Research Center
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
A broadly protective subunit vaccine against enterotoxigenic Escherichia coli (ETEC) associated diarrhea
Immune tolerance to serial trophoblast transplants
Synthetic Viral Genome Design for Rapid Vaccine Development
RoL: Molecular and cellular mechanisms of germination in Saccharomyces
Acquisition of a Low-Mass Particulate Matter Measurement and Composition Determination System for Use in Transportation Emissions Research
Recently added grants:
Quadruplet Decoding for Multiplexed Non-Canonical Amino Acid Incorporation
Lesion-centric optimization of multidrug therapies for tuberculosis
Structure of HIV-1 envelope spike in the context of membrane
Viral factors promoting the release of cell-free HSV-1
Bone neuro-mechanosignaling and inflammation: New players in diabetic osteopenia
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Blood Diseases And Resources (NHLBI)
Type
Small Business Innovation Research – Phase I (N43)
Project #
N43HB067016-001
Application #
3645657
Study Section
Project Start
1986-09-01
Project End
Budget Start
1987-07-15
Budget End
1987-02-28
Support Year
Fiscal Year
1986
Total Cost
Indirect Cost
Institution
Name
American Biogenics Corporation
Department
Type
DUNS #
City
Woburn
State
MA
Country
United States
Zip Code
01801
Related projects
NIH 1986
N43 HB
Toxicol Agents That Stimulates Fetal Hemoglobin Product
Loveday, Kenneth S. / American Biogenics Corporation
NIH 1986
N43 HB
Toxicol Agents That Stimulates Fetal Hemoglobin Product
Loveday, Kenneth S. / American Biogenics Corporation
Comments
Be the first to comment on Kenneth Loveday's grant